BACKGROUND

The MeMed BV Test produces a score that increases with increasing likelihood of bacterial infection. We evaluated its association with radiographic pneumonia in children.

METHODS

We performed a secondary analysis of a multicenter prospective study of febrile children 90 days to 18 years presenting to an emergency department. We evaluated the association of the MeMed BV test with radiographic pneumonia in adjusted logistic regression models.

RESULTS

Of 182 children, 74 (41%) had radiographic pneumonia. Among children with a high likelihood of having viral illness per the BV test, 26% had radiographic pneumonia; this increased to 64% among those with a BV test which indicated a high likelihood of bacterial infection. The sensitivity and specificity for radiographic pneumonia when using a BV test classification of moderate or high likelihood of bacterial infection were 60.8% and 62.0%, respectively. A BV test indicating the highest likelihood of bacterial infection had 23.61 higher adjusted odds (95% confidence interval 6.30–88.6) of radiographic pneumonia. The most common radiographic finding among children classified as having a high likelihood of viral infection by the BV test was interstitial opacities. The most common finding among children classified as having a high likelihood of bacterial infection were infiltrates. Except for antibiotic use, clinical outcomes occurred in similar proportions by BV category.

CONCLUSIONS

Children with moderate to high likelihoods of bacterial infection on the BV test had higher odds of radiographic pneumonia. Apart from antibiotic use, the test was not significantly associated with clinical outcomes in this study.

Lower respiratory tract infections are a common reason for pediatric health care utilization,1,2  with pneumonia accounting for a substantial cause of hospitalizations and resource use in children.3,4  Prediction models may be used to identify children at risk for radiographic pneumonia among those with suspected lower respiratory tract infections in the acute care setting to optimize diagnostic testing and use of antibiotics. Studies have found conflicting results when examining whether biomarkers, such as C-reactive protein (CRP) and procalcitonin, can assist in the diagnosis of pneumonia in isolation.5–9  Their diagnostic ability is likely enhanced when considered in conjunction with other clinical factors.10,11 

The MeMed BV test uses a blood sample to assess and integrate the levels of 3 host immune proteins into a consolidated score. This score is intended to determine the likelihood of a bacterial immune response or coinfection as opposed to a primarily viral immune response. When initially developed, investigators evaluated 600 proteins suspected to be differentially expressed in response to infections on adult and pediatric samples; from these, feature selection identified the optimal combination of 3 proteins: CRP, interferon γ-induced protein (IP-10), and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). The 3 are combined into a score using logistic regression.12  CRP is an acute inflammatory marker that rises in a variety of proinflammatory states.13  TRAIL and IP-10 are both elevated in the setting of viral infections, whereas TRAIL is suppressed in bacterial infections.14,15  Prior work has suggested that both TRAIL and IP-10 are elevated among patients in the ED who have a confirmed viral infection.16  Models were trained using an expert panel reference standard, which included a clinical and microbiological assessment and review of data by 3 physicians (which included pediatric specialists to review cases in children).

Prior evaluations of the MeMed BV test have used outcome measures derived from expert-based adjudication panels.17–22  Limited work has attempted to correlate the assay with radiographic findings of pneumonia.17  As chest radiograph findings are associated with the use of antibiotics,23  a well performing assay could potentially decrease the reliance on radiography and promote better antimicrobial stewardship in patients who are at a low risk of community-acquired pneumonia (CAP). As the MeMed BV test is cleared for use in urgent care settings, this may be useful in settings where rapid access to chest radiography may be unavailable, such as in outpatient offices.

In this study, we sought to evaluate the association of the MeMed BV test with the presence of radiographic pneumonia among children with suspected lower respiratory tract infections. We additionally sought to evaluate the association of the MeMed BV test with clinical outcomes among these children.

We performed a secondary analysis of AutoPilot-Dx, a multicenter observational prospective cohort study. Methods of this study are described elsewhere,19  with relevant aspects described here. This study was approved by the investigator’s Institutional Review Board and adhered to the Strengthening the Reporting of Observational studies in Epidemiology guidelines for reporting of observational data.24 

Children were recruited from 2 university hospitals’ EDs, 1 in Germany and 1 in Italy, irrespective of their ED disposition (admission or discharge). Consecutively enrolled eligible patients were between 90 days to 18 years of age, had an illness duration of ≤7 days, and had either a respiratory tract infection or a fever without source were approached for consent for participation, which included the collection of a blood sample (irrespective of whether blood testing was ordered by the treating clinician). Fever was defined as temperature ≥38.0°C at home or in the ED. Patients with a recent febrile episode (within 2 weeks), antibiotic use of more than 48 hours, HIV or hepatitis B or C virus infections, primary immunodeficiencies, active malignancies, severe developmental delay, and severe congenital metabolic disorders, or who were taking immunosuppressive or immunomodulatory treatment were excluded.19  For the present analysis, we limited the sample to include only those who had a chest radiograph performed as a part of their testing and who had imaging available for radiologist interpretation.

Our primary outcome was radiographic pneumonia. We used this definition as chest radiographs are frequently obtained in the acute care setting to determine if a child has pneumonia,25  and because, although radiography alone cannot differentiate between viral and bacterial etiology, radiographic pneumonia is frequently used as starting point for the initiation of therapy. For this study, each image was reviewed by board-certified pediatric radiologists who independently reviewed images, blinded to the original chest radiograph interpretation and all clinical data, and input data into a standardized data entry form. Chest radiographs were ascertained for the presence of any of the following: interstitial opacities, hyperinflation, atelectasis, alveolar infiltrates, and pleural effusions. Alveolar infiltrates were further defined as patchy versus lobar infiltrates and as focal, multifocal, or diffuse.26,27  We defined radiographic pneumonia as an interpretation of infiltrate, with or without concomitant atelectasis. Our secondary outcomes included hospitalization, length of stay, ICU admission, use of supplemental oxygen, performance of thoracocentesis, and use of antibiotics.

Our predictor of interest was the MeMed BV test. MeMed has classified the continuous BV score (which ranges from 0–100, based on the probability of bacterial infection) into 5 groups (hereafter referred to as BV test): high likelihood of viral infection or nonbacterial (BV score 0–10), moderate likelihood of viral infection or nonbacterial (11–34), equivocal (35–65), moderate likelihood of bacterial infection (66–89), and high likelihood of bacterial infection (90–100). Clinicians taking care of the patient did not have access to the BV results. We also considered other clinical and laboratory predictors of illness known to be associated with radiographic pneumonia that were present within the study dataset,10,11,28,29  including age, oxygen saturation in room air, lowest oxygen saturation during hospitalization, maximum temperature, and fever duration.

We compared clinical, historical, laboratory, and radiographic factors among the sample stratified by the presence of radiographic pneumonia patients using the Fisher’s exact and Wilcoxon rank-sum tests, using the Benjamini-Hochberg method to correct for multiple comparisons. We evaluated the association of the MeMed BV category and other predictors for the presence of radiographic pneumonia using univariable logistic regression. We transformed continuous predictors with restricted cubic splines, with 5 knots selected using maximum likelihood estimation with the first and last knot set at the fifth and 95th percentiles. We elected to use a splined approach to our analysis as this would allow for the modeling of potentially nonlinear relationships between continuous predictors and our outcome of radiographic pneumonia.30  Next, we constructed a multivariable model to evaluate if the MeMed BV category was associated with radiographic pneumonia after adjusting for known clinical risk factors, using a complete case approach. We expressed our results as odds ratios (OR) with 95% confidence intervals (CI) and as adjusted proportions. We described measures of diagnostic accuracy (sensitivity, specificity, positive and negative predictive value, positive and negative likelihood ratios) at each threshold of the BV test. We described differences in our clinical outcomes as numbers with percentages within each of the 5 BV test groups. As a sensitivity analysis, we repeated our multivariable analysis after multiple imputation by chained equations. Analysis was performed using the rms (version 6.3-0)31  package in R, version 4.3.2 (R Foundation for Statistical Computing, Vienna, Austria).

We evaluated models for radiographic pneumonia using the splined MeMed BV score, each of the 3 components used to calculate the BV score (CRP, TRAIL, and IP-10) and procalcitonin. We compared the OR and 95% CI for each, comparing the odds of having radiographic pneumonia among those with the first quartile relative to the third quartile of the continuous laboratory predictor in both univariable and multivariable models. As in the primary analysis, the multivariable models were fit separately to the biomarker with age, oxygen saturation on room air, maximum temperature, and fever duration. For each of these multivariable models, we calculated the area under the receiver operator characteristic curve (AUROC). We compared each model to the one constructed using the BV score by the paired DeLong test. As a posthoc analysis, we additionally constructed multivariable model including CRP and IP-10 (and the aforementioned clinical variables) and compared this to the model made using the BV score.

A total of 1008 children were enrolled in the parent study. A chest radiograph was obtained in 206 (20.4%) of these patients. Chest radiograph images were unavailable for 23 patients. Among the remainder, 1 was uninterpretable because of overexposure, leaving 182 children in the final study sample. The median age was 2.5 years (interquartile range [IQR] 1.2–4.9 years) and 58% were boys. The median BV score was 58 (IQR 10–94); this was lower among children without radiographic pneumonia (median 39, IQR 8–86) compared with those with radiographic pneumonia (median 85, IQR 34–99; P < .01).

Overall, 74 (41%) of children had infiltrates, meeting our outcome of radiographic pneumonia. One of these patients had features of both atelectasis and infiltrate. Among those with infiltrate, 55 (74.3%) had patchy infiltrates and 19 (25.7%) had lobar infiltrates. Of 74 patients with infiltrates, 42 (56.8%) were focal, 29 (39.2%) were multifocal, and 3 (4.1%) were diffuse. Among other chest radiograph features within the 182 analyzed patients, 121 (66.5%) had interstitial opacities, 13 (7.1%) had hyperinflation, and 9 (4.9%) had pleural effusions. Radiographs were normal in 27 (14.8%) patients.

Study sample characteristics among patients with and without radiographic pneumonia are provided in Table 1. Besides the BV score, variables that were different between children with and without radiographic pneumonia included oxygen saturation on room air, lowest oxygen saturation during hospitalization, duration of fever, CRP, TRAIL, and the presence of atelectasis and pleural effusions on radiography. There was no difference in IP-10 concentrations between children with and without pneumonia. Twenty-three children were classified as having a high likelihood of bacterial disease by the BV test but did not have radiographic pneumonia. Common diagnoses for these children included pneumonia (n = 7), upper respiratory tract infections (n = 3), and acute tonsillitis (n = 3).

TABLE 1

Demographic, Clinical and Laboratory Characteristics, Stratified by the Presence or Absence of Radiographic Pneumonia

VariableNo Radiographic Pneumonia (N = 108)Pneumonia (N = 74)P
Demographics    
 Age 2.5 [1.0, 5.0] 2.6 [1.4, 4.8] .96 
Clinical characteristics    
 Male sex 63 (58.3%) 42 (56.8%) 0.99 
 Room air oxygen saturation (%) 97 [94–99] 95 [92–96] <.01 
 Lowest oxygen saturation during hospitalization (%) 94 [90–97] 90 [87–94] <.01 
 Maximum temperature (°C) 39.3 [38.6–40.0] 39.5 [39.0–40.0] .60 
 Fever duration, d 2 [1–3] 3 [2–4] <.01 
Laboratory characteristics    
 CRP (mg/L) 46.1 [12.3–100] 91.5 [33.3–215] <.01 
 IP-10 (pg/mL) 361 [231–662] 415 [219–670] .79 
 TRAIL (pg/mL) 74.3 [50.8–119] 51.9 [33.5–86.0] <.01 
 PCT (ng/mL) 0.3 [0.1–1.3] 0.867 [0.2–3.8] .16 
 BV Score (1–100) 39 [8–86] 85 [34–99] <.01 
BV test    
 High likelihood of viral infection or nonbacterial 34 (31.5) 12 (16.2) <.01 
 Moderate likelihood of viral infection or nonbacterial 19 (17.6) 7 (9.5)  
 Equivocal 14 (13.0) 10 (13.5)  
 Moderate likelihood of bacterial infection 18 (16.7) 10 (13.5)  
 High likelihood of bacterial infection 23 (21.3) 35 (47.3)  
Radiographic findings    
 Interstitial opacities 69 (63.9) 52 (70.3) .61 
 Hyperinflation 8 (7.4) 5 (6.8) 0.99 
 Atelectasis 33 (30.6) 1 (1.4) <.01 
 Pleural effusion 0 (0) 9 (12.2) <.01 
VariableNo Radiographic Pneumonia (N = 108)Pneumonia (N = 74)P
Demographics    
 Age 2.5 [1.0, 5.0] 2.6 [1.4, 4.8] .96 
Clinical characteristics    
 Male sex 63 (58.3%) 42 (56.8%) 0.99 
 Room air oxygen saturation (%) 97 [94–99] 95 [92–96] <.01 
 Lowest oxygen saturation during hospitalization (%) 94 [90–97] 90 [87–94] <.01 
 Maximum temperature (°C) 39.3 [38.6–40.0] 39.5 [39.0–40.0] .60 
 Fever duration, d 2 [1–3] 3 [2–4] <.01 
Laboratory characteristics    
 CRP (mg/L) 46.1 [12.3–100] 91.5 [33.3–215] <.01 
 IP-10 (pg/mL) 361 [231–662] 415 [219–670] .79 
 TRAIL (pg/mL) 74.3 [50.8–119] 51.9 [33.5–86.0] <.01 
 PCT (ng/mL) 0.3 [0.1–1.3] 0.867 [0.2–3.8] .16 
 BV Score (1–100) 39 [8–86] 85 [34–99] <.01 
BV test    
 High likelihood of viral infection or nonbacterial 34 (31.5) 12 (16.2) <.01 
 Moderate likelihood of viral infection or nonbacterial 19 (17.6) 7 (9.5)  
 Equivocal 14 (13.0) 10 (13.5)  
 Moderate likelihood of bacterial infection 18 (16.7) 10 (13.5)  
 High likelihood of bacterial infection 23 (21.3) 35 (47.3)  
Radiographic findings    
 Interstitial opacities 69 (63.9) 52 (70.3) .61 
 Hyperinflation 8 (7.4) 5 (6.8) 0.99 
 Atelectasis 33 (30.6) 1 (1.4) <.01 
 Pleural effusion 0 (0) 9 (12.2) <.01 

Numbers in cells represent medians with interquartile ranges in brackets or counts with percentages in parenthesis. Oxygen saturation missing in 14, lowest oxygen saturation during hospitalization missing in 70, maximum temperature missing in 2, and procalcitonin missing in 9. P values corrected using the Benjamini-Hochberg method.

The most common radiographic finding among children classified as having a high likelihood of viral infection on the BV test was interstitial opacities, whereas the most common finding among children with a high likelihood of bacterial infection on the BV test was infiltrate (Supplemental Table 6). Among those with an infiltrate, children classified as having a higher likelihood of viral infections on the BV test more frequently had patchy findings (92%) with lobar findings occurring infrequently (8%), whereas those with a high likelihood of bacterial infection on the BV test had a lower frequency of patchy infiltrate (57%) and a higher frequency of lobar infiltrates (43%). Among children with an infiltrate, radiographic findings were similar among febrile patients with a moderate or high likelihood of viral infection, equivocal, or moderate likelihood of bacterial infection on the BV test (Supplemental Table 7). A similar finding was noted when stratifying children based on CRP into tertiles (Supplemental Table 8).

The association of univariable splined predictors for clinical and laboratory variables are presented in Figs 1 and 2, respectively. The univariable odds of radiographic pneumonia increased with rising BV likelihood of bacterial infection, though not uniformly (Table 2). When using the high likelihood of viral infection BV test as the referent, the OR of radiographic pneumonia was similar among those with a moderate likelihood of viral infection, equivocal risk, and moderate likelihood of bacterial infection, with point estimates ranging from 1.04 to 2.02. Those with a high likelihood of bacterial infection had higher odds of radiographic pneumonia (OR 4.31, 95% CI 1.86–10.01).

FIGURE 1

Association of clinical variables with radiographic pneumonia, visualized as splined predictors.

FIGURE 1

Association of clinical variables with radiographic pneumonia, visualized as splined predictors.

Close modal
FIGURE 2

Association of laboratory variables with radiographic pneumonia, visualized as splined predictors.

FIGURE 2

Association of laboratory variables with radiographic pneumonia, visualized as splined predictors.

Close modal
TABLE 2

Univariable and Multivariable Associations of the BV Test With Radiographic Pneumonia

VariableUnivariable OR (95% CI)Complete Case ApproachMultiple Imputation Approach
Multivariable OR (95% CI)Adjusted ProportionMultivariable OR (95% CI)Adjusted Proportion
High likelihood of viral infection or nonbacterial Ref Ref .21 Ref .22 
Moderate likelihood of viral infection or nonbacterial 1.04 (0.35–3.09) 2.69 (0.66–10.99) .31 2.45 (0.63–9.55) .27 
Equivocal 2.02 (0.71–5.75) 9.62 (1.94–47.81) .56 7.59 (1.74–33.26) .39 
Moderate likelihood of bacterial infection 1.57 (0.57–4.34) 7.81 (1.84–33.23) .27 6.74 (1.68–27.12) .27 
High likelihood of bacterial infection 4.31 (1.86–10.01) 23.61 (6.30–88.6) .70 20.59 (5.94–71.31) .66 
VariableUnivariable OR (95% CI)Complete Case ApproachMultiple Imputation Approach
Multivariable OR (95% CI)Adjusted ProportionMultivariable OR (95% CI)Adjusted Proportion
High likelihood of viral infection or nonbacterial Ref Ref .21 Ref .22 
Moderate likelihood of viral infection or nonbacterial 1.04 (0.35–3.09) 2.69 (0.66–10.99) .31 2.45 (0.63–9.55) .27 
Equivocal 2.02 (0.71–5.75) 9.62 (1.94–47.81) .56 7.59 (1.74–33.26) .39 
Moderate likelihood of bacterial infection 1.57 (0.57–4.34) 7.81 (1.84–33.23) .27 6.74 (1.68–27.12) .27 
High likelihood of bacterial infection 4.31 (1.86–10.01) 23.61 (6.30–88.6) .70 20.59 (5.94–71.31) .66 

The multivariable model was adjusted for age, oxygen saturation in room air, maximum temperature, and fever duration (all as splined predictors).

Complete data were available for 166 patients (91.2% of the total sample). In a multivariable model combining the BV category and the splined clinical predictors of age, oxygen saturation in room air, maximum temperature, and fever duration, the BV test group corresponding to a moderate likelihood of viral infection had similar performance to those classified as having a high likelihood of a viral infection. The odds of pneumonia in the equivocal and moderate likelihood of bacterial infection were similar (OR 9.62 [95% CI 1.94–47.81] and 7.81 [95% CI 1.84–33.23], respectively). The odds of radiographic pneumonia among children with of a high likelihood of bacterial infection were substantially higher (OR 23.61 [95% CI 6.30–88.6]). Confidence intervals overlapped across all BV test groups. Our findings were similar when using a multiple imputation approach. When evaluating measures of diagnostic accuracy, the sensitivity when using a moderate or high likelihood of bacterial infection was 60.8% and the specificity was 62.0% (Table 3). Sensitivity increased at lower thresholds, with corresponding declines in specificity.

TABLE 3

Performance of the MeMed BV Test at Different Minimum Thresholds

ThresholdSensitivitySpecificityPPVNPVPLRNLR
High likelihood of bacterial infection 47.3 (35.6–59.3) 78.7 (69.8–86.0) 60.3 (46.6–73.0) 68.5 (59.6–76.6) 2.2 (1.4–3.4) 0.7 (0.5–0.8) 
Moderate likelihood of bacterial infection 60.8 (48.8–72) 62.0 (52.2–71.2) 52.3 (41.3–63.2) 69.8 (59.6–78.7) 1.6 (1.2–2.2) 0.6 (0.5–0.9) 
Equivocal 74.3 (62.8–83.8) 49.1 (39.3–58.9) 50.0 (40.3–59.7) 73.6 (61.9–83.3) 1.5 (1.2–1.8) 0.5 (0.3–0.8) 
Moderate likelihood of viral infection 83.8 (73.4–91.3) 31.5 (22.9–41.1) 45.6 (37–54.3) 73.9 (58.9–85.7) 1.2 (1.0–1.4) 0.5 (0.3–0.9) 
ThresholdSensitivitySpecificityPPVNPVPLRNLR
High likelihood of bacterial infection 47.3 (35.6–59.3) 78.7 (69.8–86.0) 60.3 (46.6–73.0) 68.5 (59.6–76.6) 2.2 (1.4–3.4) 0.7 (0.5–0.8) 
Moderate likelihood of bacterial infection 60.8 (48.8–72) 62.0 (52.2–71.2) 52.3 (41.3–63.2) 69.8 (59.6–78.7) 1.6 (1.2–2.2) 0.6 (0.5–0.9) 
Equivocal 74.3 (62.8–83.8) 49.1 (39.3–58.9) 50.0 (40.3–59.7) 73.6 (61.9–83.3) 1.5 (1.2–1.8) 0.5 (0.3–0.8) 
Moderate likelihood of viral infection 83.8 (73.4–91.3) 31.5 (22.9–41.1) 45.6 (37–54.3) 73.9 (58.9–85.7) 1.2 (1.0–1.4) 0.5 (0.3–0.9) 

Numbers in parenthesis represent 95% confidence intervals. NLR, negative likelihood ratio; NPV, negative predictive value; PLR, positive likelihood ratio; PPV, positive predictive value.

Clinical outcomes among children within the study sample were similar across BV scores with respect to hospitalization, length of stay, and use of the ICU. Use of antibiotics was lower among those with a high likelihood of viral infection (37%) and increased progressively among children with higher likelihood of bacterial infections by BV score (Table 4). Use of oxygen was lower among those with a higher likelihood of bacterial infection by BV score. A subgroup analysis evaluating these clinical outcomes stratified by the presence of radiographic pneumonia demonstrated similar findings (Supplemental Tables 9 and 10).

TABLE 4

Secondary Outcomes Stratified by BV Categorization

VariableHigh Likelihood of Viral Infection or NonbacterialModerate Likelihood of Viral Infection or NonbacterialEquivocalModerate Likelihood of Bacterial InfectionHigh Likelihood of Bacterial Infection
N 46 26 24 28 58 
Hospitalization 39 (84.8) 25 (96.2) 23 (95.8) 27 (96.4) 51 (87.9) 
Hospitalization duration, days 4 [4–7] 5 [4–6] 6 [4–7] 5 [4–7] 6 [4–9] 
ICU admission 0 (0) 0 (0) 0 (0) 0 (0) 1 (1.7) 
Oxygen 39 (84.8) 18 (69.2) 19 (79.2) 23 (82.1) 35 (60.3) 
Thoracocentesis 0 (0) 0 (0) 0 (0) 0 (0) 1 (1.7) 
Antibiotics 17 (37.0) 19 (73.1) 20 (83.3) 27 (96.4) 58 (100) 
VariableHigh Likelihood of Viral Infection or NonbacterialModerate Likelihood of Viral Infection or NonbacterialEquivocalModerate Likelihood of Bacterial InfectionHigh Likelihood of Bacterial Infection
N 46 26 24 28 58 
Hospitalization 39 (84.8) 25 (96.2) 23 (95.8) 27 (96.4) 51 (87.9) 
Hospitalization duration, days 4 [4–7] 5 [4–6] 6 [4–7] 5 [4–7] 6 [4–9] 
ICU admission 0 (0) 0 (0) 0 (0) 0 (0) 1 (1.7) 
Oxygen 39 (84.8) 18 (69.2) 19 (79.2) 23 (82.1) 35 (60.3) 
Thoracocentesis 0 (0) 0 (0) 0 (0) 0 (0) 1 (1.7) 
Antibiotics 17 (37.0) 19 (73.1) 20 (83.3) 27 (96.4) 58 (100) 

Cells represent N (%) or median [IQR].

The BV score was significantly associated with radiographic pneumonia in univariable and multivariable analyses (Table 5). CRP, TRAIL, IP-10, and procalcitonin did not have significant univariable associations with radiographic pneumonia but were associated with this outcome in multivariable analyses. The highest AUROC for the multivariable models was found with the BV score (0.87), followed by the TRAIL (0.86) and CRP (0.85), though 95% CI of the AUROC for each of these models overlapped. The performance of models using CRP, TRAIL, and procalcitonin were similar compared with the performance of the model using the BV score. A model which used IP-10 and CRP (but not TRAIL) had similar performance to the BV score (AUROC 0.85, 95% CI 0.79–0.91; P = .38).

TABLE 5

Univariable and Multivariable Associations Between Each Laboratory Predictor (BV score, CRP, TRAIL, IP-10, and procalcitonin) and Radiographic Pneumonia

VariableUnivariable OR (95% CI)Multivariable OR (95% CI)AUROC (95% CI)P for AUROC Comparison
BV score (Q3 vs Q1) 2.75 (1.28–5.93) 11.18 (3.40–36.73) 0.87 (0.81–0.92) NA 
CRP (Q3 vs Q1) 1.17 (0.51–2.71) 5.90 (1.43–24.41) 0.85 (0.79–0.91) .30 
TRAIL (Q3 vs Q1) 0.48 (0.21–1.14) 0.18 (0.06–0.59) 0.86 (0.80–0.91) .52 
IP-10 (Q3 vs Q1) 1.09 (0.49–2.44) 0.33 (0.10–1.02) 0.80 (0.73–0.87) .01 
Procalcitonin (Q3 vs Q1) 2.23 (0.98–5.13) 5.78 (1.74–19.23) 0.83 (0.76–0.90) .14 
VariableUnivariable OR (95% CI)Multivariable OR (95% CI)AUROC (95% CI)P for AUROC Comparison
BV score (Q3 vs Q1) 2.75 (1.28–5.93) 11.18 (3.40–36.73) 0.87 (0.81–0.92) NA 
CRP (Q3 vs Q1) 1.17 (0.51–2.71) 5.90 (1.43–24.41) 0.85 (0.79–0.91) .30 
TRAIL (Q3 vs Q1) 0.48 (0.21–1.14) 0.18 (0.06–0.59) 0.86 (0.80–0.91) .52 
IP-10 (Q3 vs Q1) 1.09 (0.49–2.44) 0.33 (0.10–1.02) 0.80 (0.73–0.87) .01 
Procalcitonin (Q3 vs Q1) 2.23 (0.98–5.13) 5.78 (1.74–19.23) 0.83 (0.76–0.90) .14 

Multivariable models were adjusted for age, oxygen saturation on room air, maximum temperature, and fever duration (all as splined predictors).

We performed a secondary analysis of data from a prospective cohort study to evaluate the association between the BV assay and radiographic pneumonia in children. Children with equivocal, moderate, and high likelihoods of bacterial infection had higher odds of having radiographic pneumonia. Besides antibiotic use, the BV test was not meaningfully associated with clinical outcomes examined in this study.

Our findings corroborate prior work evaluating the performance of the BV test in children, which have focused on expert adjudication as the outcome measure. Prior work evaluating the MeMed BV test used expert adjudication as the reference etiologic standard. In the parent study by Papan et al, a direct comparison between children determined (by expert consensus) to have a bacterial or viral infection (after removing children with indeterminate etiology), the assay demonstrated a sensitivity of 93.7% and a specificity of 94.0%.19  We expand upon this work by performing a granular analysis of children with suspected pneumonia using an outcome of radiographic pneumonia instead of expert adjudication.

The BV test did not perfectly discriminate patients with and without radiographic pneumonia. Radiographic findings of infiltrate can be found in children with pneumonia regardless of the etiology of the infection (eg, viral or bacterial); this is important given the decline of suspected bacterial CAP after the introduction of pneumococcal vaccination in developed countries.32  Prior work has suggested that radiographic findings poorly discriminate between the etiology of pneumonia,33  though notably more children with lobar infiltrates were classified as having a high likelihood of bacterial infection in our study. Prior literature and national guidelines emphasize that chest radiography cannot be used to discriminate etiology of pneumonia.34,35  As such, the assumption that all radiographic pneumonia is caused by bacterial infections, as described in some previous work, is lacking definitive evidence. In this study, approximately 28% of children with radiographic pneumonia had either a high or moderate likelihood of a viral infection based on the BV test.

The BV test in isolation may not be adequate to identify which children may be at the highest risk of radiographic disease, particularly as its performance was similar to CRP in isolation and procalcitonin. As such, more research is required to determine if the MeMed test offers greater potential in the prediction of radiographic pneumonia given its specificity to pathogen-based host response. In a study of adults and children presenting to an American ED where clinicians had access to the BV test results before clinical decision-making (30% had a diagnosis of pneumonia), 83% of patients with suspected bacterial disease by BV assay were given antibiotics, compared with 23% of patients with viral illness. These findings suggest that clinicians may be amenable to using the BV assay to assist with antimicrobial decision-making.36  Additional research is required to evaluate how the timing of biomarker acquisition may impact decision-making (eg, collected during the initial part of the encounter, before review radiography results, or after, to determine a need for antibiotic). This requires buy-in among key partners, such as front-line clinicians and patient caregivers.

Finally, we observed differences in radiographic findings based on BV test results. Patients with a higher likelihood of bacterial infection on the BV test more frequently had lobar infiltrates compared with those with a higher likelihood of viral infection. These findings suggest that the BV test may have a role in limiting antimicrobial use among children with radiographic pneumonia, which is beneficial given the ambiguity in national guidelines on antibiotic use in pediatric pneumonia.35  However, a similar difference in radiographic infiltrates was observed when stratifying patients by CRP. Since etiology cannot be definitively determined from radiographic findings, further research is needed to better evaluate the role of the MeMed test in safely reducing antibiotic use in children with suspected pneumonia.

Our findings are subject to limitations. This was a secondary analysis of a previously performed prospective study. As such, we were unable to include some variables that have been demonstrated to be associated with pneumonia in our clinical models (such as auscultatory findings).28,29  As with the parent study, the study sample may be subject to ascertainment bias: as enrolled children were required to provide blood samples, those with lower acuity disease may have more frequently declined participation. Some variables (such as oxygen saturation and procalcitonin) were missing, though this occurred infrequently. Our findings when using splined predictors may be impacted by the smaller sample size, leading to broad confidence intervals. Although the MeMed BV results were not available to the treating clinician, other laboratory test results (including CRP, which is a component of the BV test) were available if ordered clinically; this in turn may have impacted decisions to acquire a chest radiograph and impacted secondary outcomes, such as decisions to treat with antibiotics. Despite these limitations, the findings from this study represent an important evaluation of a novel assay for the identification of radiographic pneumonia in children, which has not been reported in the literature.

We evaluated the association of the MeMed BV assay with pediatric radiographic pneumonia. When used in isolation, the BV score is associated with pneumonia, although this did not occur in a uniform manner with rising predicted risk of bacterial infection. This effect was magnified in multivariable models that incorporated clinical variables. Besides antibiotic use, the BV test was not associated with clinical outcomes. Further research is needed in larger samples to better understand its role in the management of pediatric pneumonia, including possible development of multivariable models that incorporate this assay.

We thank Anne Lakes (Ann & Robert H. Lurie Children’s Hospital of Chicago) for assistance with data acquisition for this study.

Dr Ramgopal conceptualized and designed the study, conducted the initial analyses, and drafted the initial manuscript; Dr Lorenz conducted the initial analyses and critically reviewed and revised the manuscript; Drs Neveu and Krauss collected data and critically reviewed and revised the manuscript; Drs Papan, Tenenbaum, and Esposito collected data, designed the data collection instruments, and critically reviewed and revised the manuscript; Dr Florin conceptualized and designed the study and critically reviewed and revised the manuscript; and all authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

FUNDING: The reported analysis received no external funding. The parent study (Autopilot-Dx) was supported by the European Commission, Executive Agency for Small and Medium-sized Enterprises, Horizon2020-FTIPilot-2015-1 program (grant 701088).

CONFLICT OF INTEREST DISCLOSURES: The authors have indicated they have no conflicts of interest relevant to this article to disclose.

1
Tong
S
,
Amand
C
,
Kieffer
A
,
Kyaw
MH
.
Trends in healthcare utilization and costs associated with pneumonia in the United States during 2008–2014
.
BMC Health Serv Res
.
2018
;
18
(
1
):
715
2
Pelletier
AJ
,
Mansbach
JM
,
Camargo
CA
 Jr
.
Direct medical costs of bronchiolitis hospitalizations in the United States
.
Pediatrics
.
2006
;
118
(
6
):
2418
2423
3
Keren
R
,
Luan
X
,
Localio
R
, et al
;
Pediatric Research in Inpatient Settings (PRIS) Network
.
Prioritization of comparative effectiveness research topics in hospital pediatrics
.
Arch Pediatr Adolesc Med
.
2012
;
166
(
12
):
1155
1164
4
Parikh
K
,
Hall
M
,
Blaschke
AJ
, et al
.
Aggregate and hospital-level impact of national guidelines on diagnostic resource utilization for children with pneumonia at children’s hospitals
.
J Hosp Med
.
2016
;
11
(
5
):
317
323
5
Sartori
LF
,
Zhu
Y
,
Grijalva
CG
, et al
.
Pneumonia severity in children: utility of procalcitonin in risk stratification
.
Hosp Pediatr
.
2021
;
11
(
3
):
215
222
6
Gunaratnam
LC
,
Robinson
JL
,
Hawkes
MT
.
Systematic review and meta-analysis of diagnostic biomarkers for pediatric pneumonia
.
J Pediatric Infect Dis Soc
.
2021
;
10
(
9
):
891
900
7
Nijman
RG
,
Vergouwe
Y
,
Thompson
M
, et al
.
Clinical prediction model to aid emergency doctors managing febrile children at risk of serious bacterial infections: diagnostic study
.
BMJ
.
2013
;
346
:
f1706
8
Irwin
AD
,
Grant
A
,
Williams
R
, et al
.
Predicting risk of serious bacterial infections in febrile children in the emergency department
.
Pediatrics
.
2017
;
140
(
2
):
e20162853
9
Florin
TA
,
Ambroggio
L
,
Brokamp
C
, et al
.
Biomarkers and disease severity in children with community-acquired pneumonia
.
Pediatrics
.
2020
;
145
(
6
):
e20193728
10
Oostenbrink
R
,
Thompson
M
,
Lakhanpaul
M
,
Steyerberg
EW
,
Coad
N
,
Moll
HA
.
Children with fever and cough at emergency care: diagnostic accuracy of a clinical model to identify children at low risk of pneumonia
.
Eur J Emerg Med
.
2013
;
20
(
4
):
273
280
11
Ramgopal
S
,
Ambroggio
L
,
Lorenz
D
,
Shah
SS
,
Ruddy
RM
,
Florin
TA
.
Incorporation of biomarkers into a prediction model for paediatric radiographic pneumonia
.
ERJ Open Res
.
2023
;
9
(
2
):
00339-2022
12
Oved
K
,
Cohen
A
,
Boico
O
, et al
.
A novel host-proteome signature for distinguishing between acute bacterial and viral infections
.
PLoS One
.
2015
;
10
(
3
):
e0120012
13
Volanakis
JE
.
Human C-reactive protein: expression, structure, and function
.
Mol Immunol
.
2001
;
38
(
2-3
):
189
197
14
Liu
M
,
Guo
S
,
Hibbert
JM
, et al
.
CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications
.
Cytokine Growth Factor Rev
.
2011
;
22
(
3
):
121
130
15
Falschlehner
C
,
Schaefer
U
,
Walczak
H
.
Following TRAIL’s path in the immune system
.
Immunology
.
2009
;
127
(
2
):
145
154
16
van der Does
Y
,
Tjikhoeri
A
,
Ramakers
C
,
Rood
PPM
,
van Gorp
ECM
,
Limper
M
.
TRAIL and IP-10 as biomarkers of viral infections in the emergency department
.
J Infect
.
2016
;
72
(
6
):
761
763
17
Stein
M
,
Lipman-Arens
S
,
Oved
K
, et al
.
A novel host-protein assay outperforms routine parameters for distinguishing between bacterial and viral lower respiratory tract infections
.
Diagn Microbiol Infect Dis
.
2018
;
90
(
3
):
206
213
18
Srugo
I
,
Klein
A
,
Stein
M
, et al
.
Validation of a novel assay to distinguish bacterial and viral infections
.
Pediatrics
.
2017
;
140
(
4
):
e20163453
19
Papan
C
,
Argentiero
A
,
Porwoll
M
, et al
.
A host signature based on TRAIL, IP-10, and CRP for reducing antibiotic overuse in children by differentiating bacterial from viral infections: a prospective, multicentre cohort study
.
Clin Microbiol Infect
.
2022
;
28
(
5
):
723
730
20
Eden
E
,
Srugo
I
,
Gottlieb
T
, et al
.
Diagnostic accuracy of a TRAIL, IP-10 and CRP combination for discriminating bacterial and viral etiologies at the emergency department
.
J Infect
.
2016
;
73
(
2
):
177
180
21
Ashkenazi-Hoffnung
L
,
Oved
K
,
Navon
R
, et al
.
A host-protein signature is superior to other biomarkers for differentiating between bacterial and viral disease in patients with respiratory infection and fever without source: a prospective observational study
.
Eur J Clin Microbiol Infect Dis
.
2018
;
37
(
7
):
1361
1371
22
Mor
M
,
Paz
M
,
Amir
L
, et al
.
Bacterial vs viral etiology of fever: a prospective study of a host score for supporting etiologic accuracy of emergency department physicians
.
PLoS One
.
2023
;
18
(
1
):
e0281018
23
Lipshaw
MJ
,
Florin
TA
,
Krueger
S
, et al
.
Factors associated with antibiotic prescribing and outcomes for pediatric pneumonia in the emergency department
.
Pediatr Emerg Care
.
2021
;
37
(
12
):
e1033
e1038
24
von Elm
E
,
Altman
DG
,
Egger
M
,
Pocock
SJ
,
Gøtzsche
PC
,
Vandenbroucke
JP
;
STROBE Initiative
.
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
.
Lancet
.
2007
;
370
(
9596
):
1453
1457
25
Ramgopal
S
,
Lorenz
D
,
Ambroggio
L
,
Navanandan
N
,
Cotter
JM
,
Florin
TA
.
Identifying potentially unnecessary hospitalizations in children with pneumonia
.
Hosp Pediatr
.
2022
;
12
(
9
):
788
806
26
Guo
W
,
Wang
J
,
Sheng
M
,
Zhou
M
,
Fang
L
.
Radiological findings in 210 paediatric patients with viral pneumonia: a retrospective case study
.
Br J Radiol
.
2012
;
85
(
1018
):
1385
1389
27
Virkki
R
,
Juven
T
,
Rikalainen
H
,
Svedström
E
,
Mertsola
J
,
Ruuskanen
O
.
Differentiation of bacterial and viral pneumonia in children
.
Thorax
.
2002
;
57
(
5
):
438
441
28
Ramgopal
S
,
Ambroggio
L
,
Lorenz
D
,
Shah
SS
,
Ruddy
RM
,
Florin
TA
.
A prediction model for pediatric radiographic pneumonia
.
Pediatrics
.
2022
;
149
(
1
):
e2021051405
29
Lipsett
SC
,
Hirsch
AW
,
Monuteaux
MC
,
Bachur
RG
,
Neuman
MI
.
Development of the novel pneumonia risk score to predict radiographic pneumonia in children
.
Pediatr Infect Dis J
.
2022
;
41
(
1
):
24
30
30
Marrie
RA
,
Dawson
NV
,
Garland
A
.
Quantile regression and restricted cubic splines are useful for exploring relationships between continuous variables
.
J Clin Epidemiol
.
2009
;
62
(
5
):
511
7.e1
31
Harrell
FE
.
Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis
.
Springer
New York
;
2013
32
Griffin
MR
,
Zhu
Y
,
Moore
MR
,
Whitney
CG
,
Grijalva
CG
.
U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination
.
N Engl J Med
.
2013
;
369
(
2
):
155
163
33
Swingler
GH
,
Zwarenstein
M
,
Cochrane Acute Respiratory Infections Group
.
WITHDRAWN: chest radiograph in acute respiratory infections
.
Cochrane Database Syst Rev
.
2009
;
2009
(
4
):
CD001268
34
Harris
M
,
Clark
J
,
Coote
N
, et al
;
British Thoracic Society Standards of Care Committee
.
British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011
.
Thorax
.
2011
;
66
(
Suppl 2
):
ii1
ii23
35
Bradley
JS
,
Byington
CL
,
Shah
SS
, et al
.
The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America
.
Clin Infect Dis
.
2011
;
53
(
7
):
e25
76
36
Novak
D
,
Masoudi
A
,
Shaukat
B
, et al
.
MeMed BV testing in emergency department patients presenting with febrile illness concerning for respiratory tract infection
.
Am J Emerg Med
.
2023
;
65
:
195
199

Supplementary data